Search Results 201-210 of 15400 for TNF

  1. CAST-AI: Cystectomy after systemic therapy with ADC and Immunotherapy - Mayo Clinic

    ... tumor necrosis factor (TNF) or anti-interleukin (IL)-6 agents are excluded * Participants still recovering from toxicity of prior anticancer therapy which ...

  2. Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer - Mayo Clinic

    ... tumor necrosis factor [anti-TNF] agents) within 6 weeks prior to cycle 1 day 1: Patients who have received acute, low dose, systemic immunosuppressant ...

  3. Induction Therapy With RO7790121 in Patients With Moderately To Severely Active Ulcerative Colitis - Mayo Clinic

    RO7790121 is a fully human immunoglobulin G1 monoclonal antibody (mAb) against tumor necrosis factor-like ligand 1A (TL1A). TL1A plays a central role in the ...

  4. JavaScript is disabled. In order to continue, we need to verify that you're not a robot. This requires JavaScript. Enable JavaScript and then reload the page.

  5. A Study to Evaluate CC-98633 to Treat Subjects with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    ... TNF, anti-IL6, or anti-IL6R) or in need of such therapies;; Donor lymphocyte infusions within 6 weeks before leukapheresis;; Radiation to a single lesion or a ...

  6. Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis - Mayo Clinic

    TNF-alpha inhibitors including but not limited to infliximab (Remicade) or ... Recently, antibodies against the proinflammatory cytokine tumor necrosis factor ...

  7. https://www.mayoclinic.org/arabic_organization_concepts.xml

  8. Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants - Mayo Clinic

    Is taking IS therapy [eg, glucocorticoids, cyclosporine, mycophenolate, tumor necrosis factor (TNF) inhibitors] for multiple sclerosis, systemic lupus ...

  9. Selected Publications by Faculty and Fellows Source: Cho, J. Seville, MT. Khanna, S. Pardi, DS. Sampathkumar, P. Kashyap, PC. Sc

    Approach to management of coccidioidomycosis in patients receiving inhibitors of tumor necrosis factor-alpha. Infectious Diseases In Clinical Practice. 2017 ...

  10. An Open-Label Pilot Study of KPL-914 in Recurrent Pericarditis - Mayo Clinic

    Currently receiving other interleukin (IL)-1 or IL-6 blockers, janus-activating kinase (JAK) or tumor necrosis factor (TNF) inhibitors. Has a history of ...